We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
This case study analyses a peer educator diabetes programme, MoPoTsyo, from a health system’s perspective
Further information on what drivers with different types of diabetes need to tell DVLA by law.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults.
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
The VIA tool shows how inpatient activity for patients with diabetes differs from a similar patient population without diabetes.
Sets out the government's quality standards for diabetes services.
Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
Experiences from a self-monitoring of blood glucose (SMBG) program in western Kenya
Individual level data of a randomized trial in a primary care setting
A retrospective cohort study involving a review of records maintained under the National Diabetes Control Programme
Declaration at a Summit in Bali, organised by the Indonesian Ministry of Health, The Union and World Diabetes Foundation
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).